Description

▪ Introduction
RIP Blend 200 by Pharma Nevis is a fast-acting injectable formulation combining three potent compounds—Testosterone Propionate, Drostanolone Propionate, and Trenbolone Acetate—delivering a total of 200 mg/mL. This synergistic blend is intended for regulated medical and analytical use where rapid hormonal and anabolic intervention is required.

Each milliliter contains:

• Testosterone Propionate – 100 mg

• Drostanolone Propionate – 50 mg

• Trenbolone Acetate – 50 mg

Designed for short-duration protocols, RIP Blend 200 supports hormonal balance, muscle preservation, and metabolic recovery under controlled conditions. The fast-acting ester profile allows flexible dosing and efficient clearance, making it suitable for intensive therapeutic cycles.

Produced to strict GMP pharmaceutical standards by Pharma Nevis, this compound ensures sterility, precision dosing, and consistent batch quality.

▪ Product Details

• Active Ingredients: Testosterone Propionate, Drostanolone Propionate, Trenbolone Acetate

• Total Concentration: 200 mg/mL

• Form: Injectable solution (intramuscular)

• Brand: Pharma Nevis

• Package Size: 10 mL multi-dose vial

• Intended Use: Professional medical or analytical research only

▪ Pharmacokinetics

• Onset of Action: Within 24–48 hours

• Half-Lives:

  • Testosterone Propionate: ~2–3 days

  • Drostanolone Propionate: ~2–3 days

  • Trenbolone Acetate: ~1–2 days

• Dosing Interval: Typically 2–3 times per week under medical supervision

▪ Usage Recommendations

• Typical Dosage: As prescribed by a licensed medical professional

• Route: Intramuscular injection

• Frequency: 2–3 times weekly or per clinical protocol

▪ Disclaimer
This product is strictly for licensed medical or analytical use in regulated environments. It is not approved for individuals under 18, pregnant or breastfeeding women, or for non-therapeutic enhancement. All usage must comply with local health regulations, ethical guidelines, and institutional policies.